Informationen:
Fehler:
ID
28679
Beschreibung
Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism; ODM derived from: https://clinicaltrials.gov/show/NCT01012193
Link
https://clinicaltrials.gov/show/NCT01012193
Stichworte
Versionen (1)
- 25.01.18 25.01.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
25. Januar 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Coronary Artery Disease NCT01012193
Eligibility Coronary Artery Disease NCT01012193
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Coronary Artery Disease NCT01012193
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Coronary Stenosis Percentage
Item
significant coronary artery stenosis (>70% by visual estimate)
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])
Coronary stent placement elective
Item
elective coronary stent implantation
boolean
C0948884 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C0439608 (UMLS CUI [1,2])
Myocardial Infarction
Item
acute myocardial infarction
boolean
C0027051 (UMLS CUI [1])
Hemorrhage | Bleeding tendency
Item
active bleeding and bleeding diatheses
boolean
C0019080 (UMLS CUI [1])
C1458140 (UMLS CUI [2])
C1458140 (UMLS CUI [2])
Hemodynamic instability
Item
hemodynamic instability
boolean
C0948268 (UMLS CUI [1])
Anticoagulation Therapy Oral | Warfarin
Item
oral anticoagulation therapy with warfarin
boolean
C0003281 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0043031 (UMLS CUI [2])
C1527415 (UMLS CUI [1,2])
C0043031 (UMLS CUI [2])
Platelet Glycoprotein IIb/IIIA Inhibitors Use of During Procedure
Item
use of peri-procedural glycoprotein iib/iiia inhibitors
boolean
C1373125 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
C1524063 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
Medical contraindication Antiplatelet therapy
Item
contraindication to antiplatelet therapy
boolean
C1301624 (UMLS CUI [1,1])
C1096021 (UMLS CUI [1,2])
C1096021 (UMLS CUI [1,2])
Left ventricular ejection fraction
Item
left ventricular ejection fraction < 30%
boolean
C0428772 (UMLS CUI [1])
White Blood Cell Count procedure | Platelet Count measurement | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
leukocyte count < 3,000/mm3, platelet count < 100,000/mm3, ast or alt ≥ 3 times upper normal
boolean
C0023508 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0032181 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
Creatinine measurement, serum
Item
serum creatinine level ≥ 3 mg/dl
boolean
C0201976 (UMLS CUI [1])
Cerebrovascular accident
Item
stroke within 3 months
boolean
C0038454 (UMLS CUI [1])
Disease | Exception Heart Diseases | Life Expectancy
Item
noncardiac disease with a life expectancy < 1 year
boolean
C0012634 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
Protocol Compliance Unable
Item
inability to follow the protocol
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])